Iván O. Rosas

Active 2006–2026

Also published as
Ivan O. Rosas · Ivan O Rosas
148
Papers
21,041
Citations
76
h-index
142
i10-index

Citations

Citations per year for Iván O. Rosas2001: 1 citations2007: 4 citations2008: 7 citations2009: 11 citations2010: 36 citations2011: 62 citations2012: 72 citations2013: 99 citations2014: 86 citations2015: 136 citations2016: 182 citations2017: 198 citations2018: 189 citations2019: 587 citations2020: 916 citations2021: 1,245 citations2022: 1,170 citations2023: 945 citations2024: 1,404 citations2025: 710 citations2026: 23 citations2002–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,679 citing papers, 27% of this breakdownChina: 1,342 citing papers, 13.5% of this breakdownUnited Kingdom: 684 citing papers, 6.9% of this breakdownGermany: 522 citing papers, 5.3% of this breakdownItaly: 410 citing papers, 4.1% of this breakdownCanada: 387 citing papers, 3.9% of this breakdownFrance: 358 citing papers, 3.6% of this breakdownJapan: 333 citing papers, 3.4% of this breakdownSpain: 254 citing papers, 2.6% of this breakdownSouth Korea: 225 citing papers, 2.3% of this breakdownNetherlands: 221 citing papers, 2.2% of this breakdownAustralia: 217 citing papers, 2.2% of this breakdown
0%27%Other 23%

Fields

  • Medicine72%
  • Biochemistry, Genetics and Molecular Biology20%
  • Immunology and Microbiology4.7%
  • Neuroscience0.7%
  • Engineering0.5%
  • Environmental Science0.5%
  • Other1.6%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis12.6%
  • COVID-19 Clinical Research Studies3.6%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3%
  • Neonatal Respiratory Health Research2.9%
  • Pulmonary Hypertension Research and Treatments2.7%
  • Systemic Sclerosis and Related Diseases2.5%
  • Other72.7%

Coauthors

All papers

Open in search
  1. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

    Authors: , , - Annual Review of Pathology Mechanisms of Disease 2021 cited by 792

  2. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis

    Authors: , , , , , , , , , , , , , - Nature Communications 2020 cited by 756

  3. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 458

  4. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

    Authors: , , , , , , , , , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2014 cited by 814

  5. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Filer, Fiona Powrie, Christopher D. Buckley, Michael B. Brenner, Soumya Raychaudhuri - Med 2022 cited by 224

  6. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 cited by 502

  7. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson and 7 more - The Lancet Respiratory Medicine 2022 cited by 208

  8. Characterization of the COPD alveolar niche using single-cell RNA sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 225

  9. ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 234

  10. Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent

    Authors: , , , , , , - The Journal of Experimental Medicine 2010 cited by 734

  11. Methotrexate and rheumatoid arthritis associated interstitial lung disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christophe Boissier, Lidwine Wémeau-Stervinou, René‐Marc Flipo, S. Marchand‐Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie‐Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy J. Doyle, Jay H. Ryu, Iván O. Rosas, V. Michael Holers, Cathérine Boileau, Marie‐Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2020 cited by 236

  12. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 1,091

  13. Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 615

  14. Single-cell connectomic analysis of adult mammalian lungs

    Authors: , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 242

  15. MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , - PLoS Medicine 2008 cited by 602

  16. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 228

  17. Association of Triglyceride-Glucose Index and Lung Health

    Authors: , , , , , , - CHEST Journal 2021 cited by 156

  18. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leslie P. Cousens, Joel T. Dudley, Naftali Kaminski, Gregory P. Downey - American Journal of Respiratory and Critical Care Medicine 2022 cited by 118

  19. Association Between Interstitial Lung Abnormalities and All-Cause Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher J. O’Donnell, Lenore J. Launer, Tamara B. Harrris, Vilmundur Guðnason, Edwin K. Silverman, George O'connor, George R. Washko, Iván O. Rosas, Gary M. Hunninghake, for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) and COPDGene Investigators - JAMA 2016 cited by 465

  20. Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2013 cited by 449

  21. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christophe Bécavin, Inbal Benhar, Joseph Bergenstråhle, Ludvig Bergenstråhle, Liam Bolt, Emelie Braun, Linh T. Bui, Steven Callori, Mark Chaffin, Evgeny Chichelnitskiy, Joshua Chiou, Thomas M. Conlon, Michael S. Cuoco, Anna Cuomo, Marie Deprez, Grant Duclos, Denise Fine, David S. Fischer, Shila Ghazanfar, Astrid Gillich, Bruno Giotti, Joshua Gould, Minzhe Guo, Austin J. Gutierrez, Arun C. Habermann, Tyler Harvey, Peng He, Xiaomeng Hou, Lijuan Hu, Yan Hu, Alok Jaiswal, Lu Ji, Peiyong Jiang, Theodoros Kapellos, Christin S. Kuo, Ludvig Larsson, Michael Leney-Greene, Kyungtae Lim, Monika Litviňuková, Leif S. Ludwig, Soeren Lukassen, Wendy Luo, Henrike Maatz, Elo Madissoon, Lira Mamanova, Kasidet Manakongtreecheep, Sylvie Leroy, Christoph H. Mayr, Ian Mbano, Alexi McAdams, Ahmad N. Nabhan, Sarah K. Nyquist, Lolita Penland, Olivier Poirion, Sergio Poli, Cancan Qi, Rachel Queen, Daniel Reichart, Iván O. Rosas, Jonas C. Schupp, Conor Shea, Xingyi Shi, Rahul Sinha, Rene Sit, Kamil Slowikowski, Michal Slyper, Neal P. Smith, Alex Sountoulidis, Maximilian Strunz, Travis Sullivan and 135 more - Nature Medicine 2021 cited by 373

  22. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 258

  23. A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 101

  24. Single Cell RNA-seq reveals ectopic and aberrant lung resident cell populations in Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 1,418